Related Experiment Video
Updated: Aug 15, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Inflammation-based Indices Predicting Mortality in COVID-19
Gokhan Cakirca1, Tuba Damar Cakirca2, Ahmet Bindal3
1Department of Biochemistry, Sanliurfa Mehmet Akif Inan Training and Research Hospital, Sanliurfa, Turkey.
Insights
Prognostic nutritional index (PNI), C-reactive protein/lymphocyte ratio (CLR), and neutrophil/lymphocyte ratio (NLR) effectively predict COVID-19 mortality. These inflammation-based markers offer valuable insights for patient outcomes.
Area of Science:
- Infectious Diseases
- Immunology
- Critical Care Medicine
Background:
- COVID-19 poses a significant global health threat, with mortality influenced by complex host responses.
- Inflammation-based indices are increasingly explored as prognostic markers in critical illnesses.
Purpose of the Study:
- To evaluate the efficiency of various inflammation-based indices in predicting mortality among COVID-19 patients.
- To identify independent predictors of mortality in a cohort of COVID-19 patients.
Main Methods:
- Retrospective analysis of 827 COVID-19 patients (733 survivors, 94 non-survivors).
- Assessment of neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), C-reactive protein/lymphocyte ratio (CLR), albumin/globulin ratio (AGR), HALP, systemic immune-inflammatory index (SII), and prognostic nutritional index (PNI).
- Multivariate analysis to determine independent predictors of mortality.
Main Results:
- Non-survivors exhibited significantly higher NLR, PLR, CLR, and SII compared to survivors.
- Non-survivors had significantly lower LMR, PNI, HALP, and AGR.
- Multivariate analysis identified PNI, NLR, CLR, older age, male gender, and dyslipidemia as independent mortality predictors.
- PNI demonstrated the largest area under the curve for mortality prediction, followed by CLR and NLR.
Conclusions:
- PNI, NLR, and CLR are identified as independent and significant predictors of mortality in COVID-19 patients.
- These inflammation-based indices can aid in risk stratification and management of severe COVID-19 cases.
- Further research can explore the clinical utility of these markers in COVID-19 prognosis.
Abstract:
Efficiency of various inflammation-based indices, including neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), C-reactive protein/lymphocyte ratio (CLR), albumin/globulin ratio (AGR), haemoglobin, albumin, lymphocyte, and platelet (HALP), systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI), was examined in predicting mortality in COVID-19 patients. The study population consisted of 827 COVID-19 patients, including 733 survivors and 94 non-survivors. Compared with the survivor group, the NLR, PLR, CLR, and SII values of the non-survivor group were markedly higher; however, the LMR, PNI, HALP and AGR values were markedly lower. Multivariate analysis identified PNI, NLR, CLR, older age, male gender and dyslipidemia as independent factors for mortality in COVID-19 patients. PNI had the largest area under the curve to predict mortality, followed by CLR, NLR, and other indexes. This data revealed that PNI, NLR, and CLR are independent factors of mortality in COVID-19 patients among inflammation-based indexes. Key Words: COVID-19 mortality, Prognostic nutritional index, C-reactive protein/lymphocyte ratio, Neutrophil/lymphocyte ratio.
Related Concept Videos
Inflammation
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Myocarditis III: Medical Management

